发明申请
US20110250210A1 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
失效
针对血小板因子-4变体1（PF4V1）的中和抗体及其片段
- 专利标题： Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
- 专利标题（中）： 针对血小板因子-4变体1（PF4V1）的中和抗体及其片段
-
申请号： US13122468申请日： 2009-10-07
-
公开(公告)号： US20110250210A1公开(公告)日： 2011-10-13
- 发明人: Andreas Bikfalvi , Alexandre Dubrac , Eric Lacazette , Herve Prats
- 申请人： Andreas Bikfalvi , Alexandre Dubrac , Eric Lacazette , Herve Prats
- 优先权： EP08305648.1 20081007
- 国际申请： PCT/EP09/63005 WO 20091007
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07H21/00 ; C12N15/63 ; C12N5/10 ; C12N1/00 ; C12P21/00 ; G01N33/566 ; A61P35/00 ; A61P27/02 ; A61P7/02 ; A61P7/00 ; A61P9/10 ; A61P9/12 ; A61P3/10 ; A61P9/00 ; A61P29/00 ; C07K16/24
摘要：
The present invention relates to neutralizing antibodies and fragments thereof directed against Platelet Factor-4 variant 1 (PF4v1) and their use for treating pathologies that require induction of angiogenesis or diseases associated with pathological angiogenesis.
公开/授权文献
信息查询
